Monthly Archives: July 2012

Early ART a ‘triple winner’ for patient health, partner protection, and cost-effectiveness

Expanded analysis of HPTN 052 study data show cost-effectiveness of early treatment of HIV July 31, 2012 — When the HIV Prevention Trials Network (HPTN) 052 investigators released their landmark study results last year showing that treatment can reduce HIV … Read More

Expanded analysis of HPTN 052 study results reveal additional benefits of early HIV treatment

July 31 — Study results released by the HIV Prevention Trials Network (HPTN) show additional benefits of early antiretroviral therapy (ART) in HIV clinical outcomes. Expanded analysis of HPTN 052 study data, presented July 26 at the XIX International AIDS … Read More

Pioneering study shows drug can purge dormant HIV

Cancer drug vorinostat flushes out persistent reservoirs of dormant HIV Read More

A cure for HIV? Researchers say the time is now

By Marla Broadfoot July 21, 2012 — Despite the success of antiretroviral drug therapy, more people contract HIV every day than initiate treatment. Even if clinicians administered antiretrovirals to each infected individual – an unattainable task, especially in the developing … Read More

UNC research to be featured at world’s largest AIDS conference

Carolina faculty and students are authors on over 100 abstracts at the XIX International AIDS Conference Read More

Health, environmental, economic costs of lack of access to contraception

UNC faculty members play role in UK, Gates Foundation summit, series on family planning Read More

UNC in China: Back to the Future

This month’s Global Health Update is a guest column by Joseph Tucker, director of UNC Project-China Read More